32 per equity share for the year. This dividend for the year ended 31 March 2024 is subject to the approval of Members at the Annual General Meeting on 28 June 2024 and will be paid on or after 1 ...

The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...

The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...

Today, GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market ... approach to managing this chronic condition. With annual revenues of $39.28 billion and a steady dividend ...

Today, GSK plc (LSE/NYSE: LON:GSK), a prominent pharmaceutical company with a market capitalization ... could offer a new approach to managing this chronic condition. With annual revenues of $39.28 ...

Pharmaceutical majors AstraZeneca and GSK have partnered with competitor Takeda and nine suppliers to accelerate the adoption ...

GSK has proposed increasing pay for ... £10.6mn in 2024 — is behind competitors in global pharma. According to GSK’s 2024 annual report, published on Thursday, the chief executive’s current ...

US Transthyretin Amyloidosis Treatment Market Growth BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire / -- The U.S. transthyretin a ...